81420-2
KRAS and NRAS gene mutations found [Identifier] in Blood or Tissue by Targeted gene mutation analysis Nominal
Active
Term Description
This assay will detect mutations in exons 2, 3 and 4 of both the KRAS and NRAS genes, allowing the determination of drug response. This term was created for, but not limited in use to, the ABI PRISM SNaPshot Multiplex Kit.
Part Descriptions
LP207788-3 KRAS & NRAS gene
The KRAS gene (Kirsten rat sarcoma viral oncogene homolog) [HGNC Gene ID:6407] is located on chromosome 12p12.1. This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. [provided by RefSeq, Jul 2008] [NCBI Gene ID:3845]
Source: National Center for Biotechnology Information (NCBI) Gene
LP207788-3 KRAS & NRAS gene
The NRAS gene (neuroblastoma RAS viral (v-ras) oncogene homolog) [HGNC Gene ID:7989] is located on chromosome 1p13.2. This is an N-ras oncogene encoding a membrane protein that shuttles between the Golgi apparatus and the plasma membrane. This shuttling is regulated through palmitoylation and depalmitoylation by the ZDHHC9-GOLGA7 complex. The encoded protein, which has intrinsic GTPase activity, is activated by a guanine nucleotide-exchange factor and inactivated by a GTPase activating protein. Mutations in this gene have been associated with somatic rectal cancer, follicular thyroid cancer, autoimmune lymphoproliferative syndrome, Noonan syndrome, and juvenile myelomonocytic leukemia. [provided by RefSeq, Jun 2011] [NCBI Gene ID:4893]
Source: National Center for Biotechnology Information (NCBI) Gene
LOINC Names Get Info
- Fully-Specified Name
- KRAS & NRAS gene mutations:
Prid: Pt: Bld/Tiss: Nom: Targeted gene mutation analysis - Long Common Name
- KRAS and NRAS gene mutations found [Identifier] in Blood or Tissue by Targeted gene mutation analysis Nominal
- Short Name
- KRAS + NRAS Mut Bld/T Mut Anl
- Display Name
- KRAS and NRAS gene mutations found Targeted gene mutation analysis Nom (Bld/Tiss)
- Consumer Name Alpha Get Info
- KRAS and NRAS gene mutations found, Blood or tissue specimen
Part Model Get Info
- Component
- KRAS & NRAS gene mutations
LP452193-8
- Analyte
- KRAS & NRAS gene mutations
LP452193-8
- Component Numerator
- KRAS & NRAS gene mutations
LP452193-8
- Component Numerator Core
- KRAS & NRAS gene
LP207788-3
- Component Numerator Core Suffix
- mutations
LP452208-4
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- Prid
LP6850-4
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Bld/Tiss
LP7061-7
- System Core
- Bld/Tiss
LP7061-7
- Super System
- NULL
- Scale
- Nom
LP7750-5
- Method
- Targeted gene mutation analysis
LP95475-7
Example Answer List: LL3941-3
Source: Laboratory Corporation of America| Answer | Code | Score | Answer ID |
|---|---|---|---|
| NEGATIVE - No KRAS or NRAS mutations were detected in exons 2, 3 and 4 | LA26004-4 | ||
| POSITIVE - NRAS mutation was detected in the provided specimen. No KRAS mutations were detected in exons 2, 3 and 4. No KRAS mutations were detected in exons 2, 3 and 4. | LA26005-1 | ||
| POSITIVE - KRAS mutation was detected in the provided specimen. No NRAS mutations were detected in exons 2, 3 and 4. POSITIVE | LA26006-9 | ||
| POSITIVE - KRAS and NRAS mutations were detected in the provided specimen | LA26007-7 |
Basic Attributes
- Class
- MOLPATH.MUT
- Type
- Laboratory
- First Released
- Version 2.56
- Last Updated
- Version 2.83 (NAM)
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 16799
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Gen KRAS & NRAS cílená mutační analýza: |
| el-GR | Greek (Greece) | Γονίδιο KRAS & NRAS στοχευμένη ανάλυση μεταλλάξεων: Synonyms: MOLPATH MOLPATH.MUT Nom Prid Pt Αίμα Αίμα/Ιστός Γονίδιο Γονίδιο KRAS & |
| es-MX | Spanish (Mexico) | Análisis de mutaciones dirigidas al gen KRAS y NRAS: |
| es-ES | Spanish (Spain) | Gen KRAS y NRAS Analisis de mutaciones: |
| fr-FR | French (France) | KRAS et NRAS gène mutation cible trouvée: |
| it-IT | Italian (Italy) | KRAS & NRAS, geni analisi di mutazione mirata: Synonyms: Gene NRAS Genetica molecolare Geni KRAS & |
| nl-NL | Dutch (Netherlands) | KRAS & NRAS-gen doelgerichte mutatie-analyse: Synonyms: KRAS & |
| pl-PL | Polish (Poland) | KRAS & NRAS gen ukierunkowana analiza mutacji: Synonyms: Analiza mutacji genów KRAS i NRAS Analiza mutacji genu NRAS diagnostyka molekularna Gen KRAS i NRAS Gen NRAS wynik kategorialny |
| zh-CN | Chinese (China) | KRAS 与 NRAS 基因 突变分析: Synonyms: Kirsten大鼠肉瘤病毒癌基因同源物; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://